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Background: To analyze the impact of multimorbidity (MM) on health care costs taking into account data
heterogeneity.
Methods: Data come from a multicenter prospective cohort study of 1,050 randomly selected primary care patients
aged 65 to 85 years suffering from MM in Germany. MM was defined as co-occurrence of ≥3 conditions from a list
of 29 chronic diseases. A conditional inference tree (CTREE) algorithm was used to detect the underlying structure
and most influential variables on costs of inpatient care, outpatient care, medications as well as formal and informal
nursing care.
Results: Irrespective of the number and combination of co-morbidities, a limited number of factors influential on
costs were detected. Parkinson’s disease (PD) and cardiac insufficiency (CI) were the most influential variables for
total costs. Compared to patients not suffering from any of the two conditions, PD increases predicted mean total
costs 3.5-fold to approximately € 11,000 per 6 months, and CI two-fold to approximately € 6,100. The high total
costs of PD are largely due to costs of nursing care. Costs of inpatient care were significantly influenced by cerebral
ischemia/chronic stroke, whereas medication costs were associated with COPD, insomnia, PD and Diabetes. Except
for costs of nursing care, socio-demographic variables did not significantly influence costs.
Conclusions: Irrespective of any combination and number of co-occurring diseases, PD and CI appear to be most
influential on total health care costs in elderly patients with MM, and only a limited number of factors significantly
influenced cost.
Trial registration: Current Controlled Trials ISRCTN89818205
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Statistical learningBackground
The concept of multimorbidity (also referred to as mul-
tiple chronic conditions) relates to the coexistence of
several chronic diseases in an individual [1]. Especially
among the aged, multiple chronic conditions are com-
mon [2,3]. While there is no uniform cut-off point for* Correspondence: h.koenig@uke.uni-hamburg.de
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reproduction in any medium, provided the ormultimorbidity, the coexistence of two or more and, al-
ternatively, three or more chronic conditions are com-
monly used criteria [4]. In general, prevalence rates of
multimorbidity among persons aged 65 and older have
been widely reported to exceed 60% [5]. In a German
study based on claims data from a large sample, van den
Bussche et al. [6] found a prevalence of 62.1% for
multimorbidity, defined as three or more conditions,
among subjects aged 65 years or older and a mean num-
ber of 5.8 chronic conditions among these multimorbid
subjects. As a result of demographic change, thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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increase in Germany and most other industrialized
countries in the next decades.
Individuals with multiple chronic conditions consume
a disproportionally large share of total health services. In a
systematic literature review, Lehnert et al. [7] found ample
evidence of a positive association between multimorbidity
and health care costs. As a major result, the review
reported that costs significantly increase with each
additional chronic condition. Particularly physician
visits, hospital use, and pharmaceuticals were found to
elevate health care costs with each additional chronic
condition. Yet the effect of additional chronic conditions
on costs may depend on the number, type and combin-
ation of comorbidities with almost unlimited numbers
of possible disease combinations. This heterogeneity
can hardly be taken into account by traditional regression
models.
This study aims to analyze the impact of multimorbidity
on health care costs in Germany on all sectors of care.
Instead of taking specific patterns of single disease
combinations into account, our goal is to identify the
most relevant diseases within arbitrary morbidity patterns
influencing health care costs. Different from other studies,
it tries to detect the underlying structure of cost data by
using an improved tree-based graphical model. As a main
advantage compared to traditional analytical methods,
tree-based models allow to represent highly dimensional
data in a simple manner and to easily interpret the results.
Based on the method of automatic interaction detection
(AID) introduced by Morgan and Sonquist [8], espe-
cially classification and regression trees (CART) have
been widely used in health care research, including
the analysis of comorbidity [9–11]. Nonetheless, CARTs
tend to overfitting and a selection bias of covariates with a
maximum number of possible splits. To overcome these
weaknesses, advanced splitting algorithms like Chi-square
automatic interaction detectors (CHAID) and conditional
inference trees (CTREE) have been developed. As a limita-
tion, CHAID requires categorical data and responses,
while CTREE can deal with arbitrary scaled variables
[12,13]. To our knowledge, this analysis is the first to use




Data were collected within the MultiCare Cohort Study.
Details regarding the methods of the study and the co-
hort have been published elsewhere [14]. The analyses
presented here are based on data from the MultiCare
baseline assessment. Briefly, the MultiCare Cohort
Study is a multicenter, prospective cohort study of
multimorbid primary care patients selected randomlyfrom the databases of 158 general practitioners’ (GP)
offices at 8 study centers across Germany. The study’s
aims are to investigate multimorbidity patterns over
time, to identify patients’ resources and risk factors that
influence the course of these patterns, and to analyze
the somatic, psychological and social consequences of
these patterns for the patients’ quality of life and func-
tional status. Inclusion criteria were age between 65
and 85 years, at least one visit to the GP within the last
three-month period and multimorbidity, defined as the
coexistence of at least 3 chronic conditions from a list
of 29 conditions comprising alcohol-related disorders,
anemia, anxiety disorders, atherosclerosis/peripheral
artery occlusive disease (PAOD), asthma/chronic ob-
structive pulmonary disease (COPD), cancer, cardiac
arrhythmias, cardiac insufficiency, cardiac valve disorders,
cerebral ischemia/chronic stroke, chronic ischemic heart
disease, depression, Diabetes mellitus, dizziness, intestinal
diverticulosis, joint arthrosis, lower limb varicosis, migraine/
chronic headache, neuropathies, osteoporosis, Parkinson’s
disease, psoriasis, renal insufficiency, rheumatoid arthritis/
chronic polyarthritis, severe hearing loss, severe vision
reduction, somatoform disorders, thyroid dysfunction
and urinary incontinence. Patients were excluded from
the study if they were no regular patients of the GP.
Other exclusion criteria were inability to participate due
to medical reasons (such as blindness and deafness),
insufficient German language skills, residence in a
nursing home, and inability to provide informed consent
or participation in another ongoing study. A diagnosis of
dementia was therefore an exclusion criterion.
A total of 24,862 patients from the databases of the
participating GP practices were checked for inclusion
and exclusion criteria. 7,172 patients fulfilled the cri-
teria and were contacted for informed consent to par-
ticipate. 3,317 patients agreed to participate and were
available for the baseline interview within a time
frame of 16 months. In retrospect, 128 of these cases
had to be excluded either because, in direct contact,
exclusion criteria were found to apply or because the
patient died before the baseline interview. Thus, a
final number of 3,189 patients were included in the
study.
Of these, 1,051 patients (i.e. an approximate third of
the cohort) were randomized into a subsample in which
a comprehensive assessment of healthcare resource use
was conducted in addition to the standard MultiCare
assessment battery. Due to a missing value for health
insurance, one case was excluded from this subpopulation.
Thus, the analyses presented here are based on this sub-
sample of N = 1050. Recruitment and baseline interviews
took place between July 2008 and October 2009. The
study was approved by the Ethics Committee of the
Medical Association of Hamburg.
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Multimorbidity was assessed by means of a standardized
GP questionnaire which comprised 46 chronic condi-
tions including the 29 conditions used as inclusion cri-
teria. The list was newly compiled at the beginning of
the MultiCare study with the aim of representing the
most frequent chronic conditions in the population and
is based on prevalence data (for details, see [6,14]). Yet
in order to ensure a wide range of diseases and syn-
dromes, those with a prevalence of more than 25% were
not used as inclusion criteria for the sample, as an unse-
lected application of the three-condition-criterion would
have resulted in an overrepresentation of these very fre-
quent diseases and a small number of disease patterns in
the study population [14]. Nevertheless, these highly
prevalent conditions are frequently combined with the
relatively lower prevalent ones and therefore still part of
the sample.
In the 46 conditions, ICD-10 codes are classified to-
gether if diseases and syndromes are similar patho-
physiologically or if ICD-codes of related disorders are
used ambiguously in practice. At the beginning of the
baseline interviews, the compilation of the list had not
been quite finalized, and for this reason 7 of the condi-
tions were not part of the standardized baseline GP
questionnaire, but were assessed by means of open ques-
tions. This applies to chronic gastritis, insomnia, aller-
gies, obesity, hypotension, sexual dysfunction and
tobacco abuse. The conditions assessed in a standardized
fashion in the GP questionnaire at baseline comprise
the 29 condition used as inclusion criteria as well
as chronic cholecystitis/gallstones, chronic low back
pain, haemorrhoids, hypertension, lipid metabolism
disorders, liver diseases, noninflammatory gynaeco-
logical problems, purine/pyrimidine metabolism disor-
ders/gout, prostatic hyperplasia and urinary tract
calculi. Dementia was also listed, but constituted an ex-
clusion criterion at baseline.
Sociodemographic variables
Socio-economic status (education, income) was assessed
with an established questionnaire [15]. The level of edu-
cation was rated according to the international CASMIN
classification [16]. Income is reported as net monthly in-
come from all sources of income adjusted for household
size (this is net income divided by the equivalized house-
hold size, for which a value of 1.0 is assigned to the
householder, 0.5 is assigned to every other household
member aged 15 or over, and 0.3 is assigned to every
child under the age of 15).
Resource use
Resource use was recorded by means of a questionnaire
administered as part of the MultiCare assessmentbattery. The resource use questionnaire was devel-
oped by our working group. It is based on versions
used in previous investigations (e.g., [17–19]) and is
available from the authors upon request. The ques-
tionnaire covers in patient treatment, out-patient
physician treatment, pharmaceuticals, other kinds of
out patient treatment (such as physical or occupa-
tional therapy), medical supplies and dental pros-
theses, nursing home care, professional nursing
services and other paid help as well as informal care
(Table 1). The items for informal care are based on
an instrument by Neubauer et al. [20]. Assessment
was retrospective and covered a period of 3 months,
except for in patient treatment and nursinghome care,
for which the period was 6 months. The question-
naire contains lists of common resources and services
in order to minimize recall bias.
Health care costs
We adopted a societal perspective; therefore all re-
sources and services used were recorded, regardless of
whether they were covered by health or nursing insur-
ance or paid for out-of-pocket. The cost categories ana-
lyzed in this study are direct costs of illness arising
from the use of resources. We did not evaluate indirect
costs due to lost productivity because of the advanced
age of the subjects. Healthcare costs were calculated
for a 6-month period, multiplying resource use by two
in sections which covered a 3-month period. Costs
were calculated from resource use as recorded in
the questionnaire by means of unit costs. Resource cat-
egories and sources of unit costs are listed in Table 1.
Informal care was valued using the replacement cost
approach, i.e. it was assumed that the same amount of
care by professional nursing services would have had to
be paid for in the absence of an informal caregiver. Ac-
cordingly, hours of informal care were valued using the
same hourly wage rate as for professional home care
(see van den Berg [21] for an overview of methods for
the valuation of informal care).
Cost were calculated in € at 2009 price levels. Unit
costs that were unavailable at year 2009 values were in-
flated or deflated to year 2009 price levels by means of
the consumer price index [22].
For statistical analysis, we categorized cost data as
follows: 1) Costs of inpatient care comprising inpatient
treatment in general hospitals, specialized psychiatric
and neurological hospitals or rehabilitation clinics; 2)
costs of outpatient care comprising outpatient physician
treatment, other outpatient treatment, and medical sup-
plies and dental prostheses; 3) costs of medication com-
prising pharmaceuticals; 4) costs of nursing care
comprising nursing home care, professional home care
and informal care.
Table 1 Documented resource use and unit costs applied for calculation of costs
Sector Services / Goods Units Unit costs (Source)
Inpatient treatment Stays in general hospitals, specialized
psychiatric and neurological hospitals
or rehabilitation clinics (including
day-patient treatment)
Days in hospital Per diem costs by type (Federal Statistical
Office, German Hospital Federation,
Statutory Pension Insurance Fund [34–36])
Outpatient physician
treatment
Treatment by GPs, specialists and
outpatient clinics
Number of contacts Calculated costs per contact, by specialization [37]
Other outpatient
treatment
E.g., physiotherapy, massage, occupational
therapy, speech therapy
Number of contacts Reimbursement schedules (Statutory health
insurance funds [38–40]), calculated costs per
contact [37], by type
Medical supplies and
dental prostheses
E.g., walkers, incontinence pads, hearing
aids, surgical stockings; bridge, crown
Quantity Reimbursement schedules (Statutory health insurance
funds, Federal Association of Panel Dentists[41,42]),
calculated costs per item [37], by type
Medication Specific products (including trade name,
drug code, package size, pharmaceutical
form, dosage)
Quantity Pharmacy retail prices (Rote Liste 2008 [43])
Nursing home care Nursing home stays (residential and day care) Days Calculated costs of care per day (Federal Statistical
Office [44]), by type
Professional home care Care and assistance provided by
professional nursing services and
other paid help, differentiated by
type (e.g., basic care, assistance with
cleaning, shopping, financial matters etc.)
and limited to care or assistance required
due to illness or age
Hours Hourly gross wage rate plus non-wage labor costs for
employees in the domain of care and assistance for
the elderly or handicapped (Federal Statistical
Office [45,46])
Informal care Care and assistance provided by family
or friends, differentiated by type and limited
to care or assistance required due to illness
or age
Hours Replacement cost method: Hourly gross wage rate
plus non-wage labor costs for employees in the
domain of care and assistance for the elderly or
handicapped (Federal Statistical Office [45,46])
GP = General practitioner.
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Missing values in items of the resource use question-
naire (below 1% for all items) were imputed using the
means of the observed data for the respective items
(conditional means). Dosage of medication was an ex-
ception, however, since medications and their dosage
were too varied interindividually for mean imputation to
be possible. Therefore costs for medication with missing
values for dosage were calculated using a conservative
rule, whereby the pharmacy retail price of one package
of the drug per 3 months was applied. Missing values in
items of the standard MultiCare assessment battery were
imputed using the hot deck method, in which missing
values are replaced using observed values from a
responding unit that is as similar as possible to the non-
responding unit [23,24]. The proportion of missing
values in those items which were used in our analysis
was below 0.3%, except for income with 12.7% missings.
Statistical analyses
We used a conditional model based on a supervised
learning tree-algorithm in order to visualize a hierarch-
ical data partition and to detect the underlying structure
and most influential variables on total costs and on costs
of the four different cost sectors (inpatient care,outpatient care, medication, nursing care) separately. As
covariates we used binary variables for those 41 of the
46 diseases which had a prevalence rate of ≥1% in the
sample. In addition, we included a binary variable for
obesity (defined as body mass index ≥ 30 kg/m2). A de-
tailed list of the diseases taken into account is provided
in the Results section. Additionally, female sex (reference
category: male) and private health insurance (reference
category: statutory health insurance) were added as di-
chotomous variables. Education was included as a cat-
egorical variable, taking low education as reference.
Besides this, age and the logarithmic (log) transformed
income were included as continuous covariates. Log-
transformation was used to achieve a linear relationship
of predictors and outcomes. No additional distributional
assumptions concerning the error terms or outcomes
were made.
Traditionally, classification and regression trees
(CART) attempt to discriminate data into homogenous
subsets. Thus, node A is split into two disjunctive sub-
sets A∩ {xi ≤ c} and A∩ {xi > c} based on a single variable
Xi = xi (see [25]). As splitting criteria, the impurity of
node or entropy could be used. One main disadvantage
of CARTs is their tendency to grow huge trees by
selecting splitting variables which lead to a maximum
Table 2 Characteristics of the sample (N = 1,050)
Age: mean (SD) 74.4 (5.20) years
Gender: N (%) female 616 (58.67)
Marital status: N (%)
Married 598 (56.89)




Living situation: N (%)
Alone 370 (35.20)
With spouse/partner 613 (58.32)
With family members 40 (3.81)
With others 3 (0.29)
Assisted living 21 (2.00)





Income: mean (SD) € 1,440 (€ 737)
Number of chronic conditions (SD) 7.0 (2.50)
Type of health insurance: N (%)
private 45 (4.29)
statutory 1,005 (95.71)
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mal cut subtree could be detected using minimal cost-
complexity pruning based on cross validation (see [26]).
To overcome these disadvantages and as a superior ap-
proach to CART, we used in a first step a non-parametric
conditional inference tree (CTREE)-algorithm predicated
on recursive binary partitioning embedded in the framework
of permutation tests introduced by Strasser and Weber
[27]. Thus the distribution of the response Y is defined as
conditional on a function g of a set of k arbitrarily scaled
covariates X as f(Y|g(X1,…, Xk)).
A learning sample Ln based on a random selection of
n i.i.d. observations was used to fit the tree-structured
regression model. A vector of dichotomous case weights
w representing each node was used to create the dis-
junctive subsets wleft,i =wiI(Xi ∈A) and wright,i =wiI(Xi ∉
A) with I(⋅) as indicator function. A discrepancy measure
of the form





h Y i; Y 1;…;Ynð ÞÞT
  
was used to establish a two sample statistic for all pos-
sible subsets of A with h(⋅) as influence function. vec is
the vec-operator and (⋅)T the transpose.
At each node a global null hypothesis H0 : f(Y|Xj) = f(Y)
was tested on a pre-specified α = 0.05 level of signifi-
cance. To incorporate different scaled covariates, a
maximization of the test statistic based on the condi-
tional mean and conditional variance over all possible
subsets was established. In case of acceptance, the tree-
algorithm was interrupted and no further data-split was
performed. Otherwise the covariate Xj with the strongest
influence on Y was selected as node, and the null hy-
pothesis was tested in each subset of the tree. This ap-
proach guarantees the optimal sized tree is grown
[12,28]. To visualize the inherent structure, trees were
plotted for total costs and each cost sector.
The cost means μ^i were predicted with regard to the
number of case weights wi = 1. To evaluate the predic-
tion quality, both the squared error loss and the mean
absolute error were calculated.
In addition, in order to evaluate model performance of
CTREE, it was compared to traditional CART, which is
an alternative tree-based algorithm.
In a second step we used ensemble methods in terms
of conditional random forests. nTREE = 500 random trees
were grown to increase the performance of our predic-
tions and to verify our results [25]. As a benefit, espe-
cially random forests can deal with large covariate lists
and/or complex interaction structures. In contrast to
random forests introduced by Breimann [29], which are
based on CART, we implemented an unbiased random
forest based on CTREE [30]. Based on the unbiasedrandom forest variance, importance scores were calcu-
lated indicating the importance of certain variables for
determining the response. Basically, variable importance
measures the difference in prediction accuracy before
and after randomly permuting single covariates.
The analysis was performed using the packages party
and rpart in R 2.14.1 [31].
Results
Sociodemographic and morbidity data
The mean age of the sample at baseline was 74.4 years,
and 58.6% were female (Table 2). More than half of the
participants were married (56.9%), while approximately
one quarter were widowed (27.5%). 58.3% were living
with their spouse or partner, and 35.2% were living alone
in their own home. The proportions of subjects in
assisted living (2.0%) or retirement homes (0.3%) were
low. The majority of the sample had a low degree of
education (61.8%), and mean household-size adjusted
monthly income was € 1,440 . Only 4.3% of the partici-
pants were privately insured.
On average, the participants had 7.0 chronic condi-
tions, with no significant differences between men and
Table 3 Prevalence of chronic conditions and rank order in the sample, overall and by gender
Chronic condition Prevalence in % (rank)
Overall n = 1,050 Female n = 616 Male n = 434
Hypertension 79.4% (1) 79.5% (1) 79.3% (1)
Lipid metabolism disorders 59.4% (2) 57.5% (2) 62.2% (2)
Chronic low back pain 51.0% (3) 57.4% (3) 42.2% (5)
Joint arthrosis 43.4% (4) 50.2% (4) 33.9% (6)
Diabetes mellitus 38.2% (5) 34.4% (7) 43.5% (3)
Chronic ischemic heart disease 32.7% (6) 25.2% (11) 43.3% (4)
Obesity 31.3% (7) 35.6% (6) 25.3% (11)
Thyroid dysfunction 31.0% (8) 38.8% (5) 20.1% (14)
Cardiac arrhythmias 28.5% (9) 26.5% (10) 31.3% (7)
Osteoporosis 26.4% (10) 30.7% (8) 5.8% (33)
Asthma/COPD 23.5% (11) 20.9% (13) 27.2% (9)
Lower limb varicosis 23.1% (12) 29.4% (9) 14.3% (20.5)
Purine/pyrimidine metabolism disorders/Gout 20.2% (13) 15.3% (16.5) 27.2% (10)
Severe vision reduction 19.0% (14) 18.5% (14) 19.8% (15)
Cancer 18.1% (15) 15.3% (16.5) 22.1% (13)
Depression 17.3% (16) 21.9% (12) 10.8% (24)
Atherosclerosis/PAOD 17.2% (17) 12.7% (18) 23.7% (12)
Intestinal diverticulosis 15.4% (18) 16.1% (15) 14.5% (19)
Neuropathies 13.7% (19) 11.0% (20.5) 17.5% (16)
Chronic gastritis/GERD 13.1% (20) 12.3% (19) 14.3% (20.5)
Cardiac insufficiency 12.6% (21) 11.0% (20.5) 14.8% (18)
Renal insufficiency 12.4% (22) 9.6% (24) 16.5% (17)
Prostatic hyperplasia 11.7% (23) - 28.3% (8)
Cerebral ischemia/Chronic stroke 11.2% (24) 9.7% (22) 13.3% (22)
Cardiac valve disorders 9.1% (25) 8.9% (27) 9.5% (26)
Haemorrhoids 9.0% (26) 5.4% (31.5) 12.7% (23)
Dizziness 8.8% (27) 9.6% (24) 7.7% (28)
Chronic cholecystitis/Gallstones 8.1% (28) 8.0% (28) 8.3% (27)
Liver diseases 7.9% (29) 6.3% (29) 10.1% (25)
Somatoform disorders 7.4% (30) 9.1% (26) 5.1% (34)
Urinary incontinence 7.3% (31) 9.6% (24) 4.2% (35)
Insomnia 5.0% (32) 4.2% (35) 6.2% (31)
Severe hearing loss 4.7% (33) 3.4% (37) 6.4% (29)
Anemia 4.6% (34) 3.2% (38) 6.5% (30)
Psoriasis 4.2% (35) 2.9% (39) 6.0% (32)
Rheumatoid arthritis/Chronic polyarthritis 4.0% (36) 5.5% (30) 1.3% (40)
Anxiety 3.7% (37) 4.6% (33.5) 2.5% (37)
Allergies 3.6% (38) 4.6% (33.5) 2.3% (38.5)
Migraine/chronic headache 3.5% (39) 5.4% (31.5) 0.9% (41)
Parkinson’s disease 2.3% (40) 2.0% (40) 2.8% (36)
Noninflammatory gynaecological problems 2.1% (41) 3.6% (36) -
Urinary tract calculi 1.5% (42) 1.0% (41) 2.3% (38.5)
COPD = Chronic obstructive pulmonary disease; GERD = Gastroesophageal reflux disease; PAOD = Peripheral artery occlusive disease.
König et al. BMC Health Services Research 2013, 13:219 Page 6 of 13
http://www.biomedcentral.com/1472-6963/13/219
König et al. BMC Health Services Research 2013, 13:219 Page 7 of 13
http://www.biomedcentral.com/1472-6963/13/219women. The ten most prevalent conditions in the overall
sample, in descending order, were hypertension (79.4%),
lipid metabolism disorders (59.4%), chronic low back
pain (51.0%), joint arthrosis (43.4%), Diabetes mellitus
(38.2%), chronic ischemic heart disease (32.7%), obesity
(31.3%), thyroid dysfunction (31.0%), cardiac arrythmias
(28.5%) and osteoporosis (26.4%) (Table 3). However,
there were some differences in rank order by gender.
For instance, the prevalence of chronic ischemic heart
disease was twice as high for men (43.3%) as for women
(25.2%), for whom this condition only ranked eleventh.
Osteoporosis, by contrast, was much more common
among women, for whom this condition ranked eighth,
than among men (30.7% vs. 5.8%). Among men thyroid
dysfunction and lower limb varicosis were much less
common than among women (20.1% vs. 38.8% and
14.3% vs. 29.4%), while the ten most prevalent condi-
tions for men also included prostatic hyperplasia (28.3%,
ranking seventh) and purine/pyrimidine metabolism dis-
orders and gout (27.2%, ranking ninth). More details on
the prevalence of chronic conditions in the MultiCare
cohort have been reported elsewhere (see [32]).
Costs
In this section we present the results of the conditional
inference trees. At first we report on the analysis of total
costs, followed by costs of inpatient care, outpatient
care, medication and nursing care. All cost data refer to
a 6-month period.
Total costs
Mean total costs in the whole sample amounted to €
3,671 (SD: € 6,996), ranging from € 23 to € 101,600. The
identified tree model consisted of 5 nodes defining threeFigure 1 Conditional independence tree for total costs. PD = Parkinson
total costs in € in 6-month period.homogenous subsets based on two dichotomous disease
indicators (Figure 1). The first split was caused by the
covariate Parkinson's disease (PD) at a significance level
of p < 0.001. Given that PD occurs within the individual
multimorbidity pattern, the model predicts mean total
costs of € 11,042 (n = 24, SD: € 14,216) with no further
split. If PD is not present, a further split is caused by an-
other disease covariate indicating the presence of cardiac
insufficiency (p < 0.001). Conditional on the absence of
PD, predicted mean costs are € 6,081 (n = 129, SD:
€ 11,498) if cardiac insufficiency is present, and € 3,127
(n = 897, SD: € 5,535) if not. Thus, regardless of any
other variables taken into account or co-existing combina-
tions of diseases, total costs are influenced by the presence
or absence of PD and cardiac insufficiency.Costs of inpatient care
Mean costs of inpatient care in the whole sample
amounted to € 1,096 (SD: € 4,029), ranging from € 0 to €
92,850. For inpatient care we identified a tree-based model
consisting of only 3 nodes (Figure 2): the only split was
caused by cerebral ischemia and/or chronic stroke (CI/CS)
at a significantly level of p = 0.018. Predicted mean hos-
pital costs are € 2,337 if CI/CS is present (n = 118, SD: €
9,373), and € 939 otherwise (n = 932, SD: € 2,653).Costs of outpatient care
Mean costs of outpatient care in the whole sample
amounted to € 418 (SD: € 846), ranging from € 0 to €
25,120. For outpatient costs no split was detected at the
α =0.05 level of significance. When increasing the sig-
nificance level α to 0.2, a single split was achieved by
cardiac insufficiency (p = 0.072).’s disease; CCI = cardiac insufficiency; mean costs = predicted mean
Figure 2 Conditional independence tree for inpatient costs. CICS = cerebral ischemia and/or chronic stroke, mean costs = predicted mean
inpatient costs in € in 6-month period.
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Mean costs of medication in the whole sample
amounted to € 590 (SD: € 752), ranging from € 0 to €
15,440. With respect to medication costs, nine nodes
were identified with four chronic conditions influencing
costs (Figure 3). The first split was caused by chronic
obstructive pulmonary disease (COPD), which has a
highly significant (p < 0.001) impact on the medicationFigure 3 Conditional independence tree for medication costs. COPD =
= insomnia; DM = Diabetes mellitus, mean costs = predicted mean medicatcosts. Given that COPD is present, a further split is
caused by insomnia (p < 0.032). If COPD is present,
mean predicted medication costs amount to € 1,623 if
insomnia is also present (n = 19, SD: € 3,400) and € 727 if
not (n = 228, SD: € 587). On the other hand, if there is no
diagnosis of COPD, PD causes a further split (p < 0.001)
with predicted mean medication costs of € 1,409 if PD is
present (n = 19, SD: € 1,510). If PD is not present, a furtherchronic obstructive pulmonary disease; PD = Parkinson’s disease; INS
ion costs in € in 6-month period.
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dicted mean costs of € 614 (n = 297, SD: € 591) if present
and € 438 (n = 487, SD: € 487) if not.
Costs of nursing care
Mean costs of formal and informal nursing care in the
whole sample amounted to € 1,290 (SD: € 4,815), ran-
ging from € 0 to € 50,040. For costs of nursing care, nine
nodes were identified (Figure 4). The first split was
caused by PD, which has a highly significant impact on
costs of nursing care (p < 0.001). If PD is present, our
model predicts mean nursing care costs of € 7,014 (n = 24,
SD: € 13,475). Given that PD is not present, a further split
is caused by the logarithmic income ≤ € 6.98 (e€6.98≈
€ 1,075) or > € 6.98 (p = 0.015). Given that logarithmic
income is ≤€ 6.98, the predicted mean nursing care
costs are € 1,909 (n = 359, SD: € 5,973). If the income
is higher than that, a further split is caused by age,
with three age groups being detected: at a first step a
split is detected at >83 years (p < 0.001), leading to
predicted mean nursing care costs of € 3,910 (n = 35, SD:
€ 8,278). In case of an age ≤83 years, a further split is
caused by an age >76 years (p = 0.006), leading to pre-
dicted mean care costs of € 1,082 (n = 204, SD: € 3,418).
Alternatively, given an age below 76 years, mean nursing
care costs of € 335 (n = 428, SD: € 1,617) are predicted.
Conditional random forests and comparison with CART
Based on a conditional random forest consisting of 500
conditional random trees, variance importance scores
were calculated to verify our findings. As a main result,
the numerical order of these scores coincide with the
structure described above throughout all sectors. Thus,
we were able to confirm the accuracy of our analysisFigure 4 Conditional independence tree for costs of nursing care. PD
logarithm of income, mean costs = predicted mean costs of nursing care inusing ensemble methods. Independently of our specific
sample, we detected the factors most influential on costs
irrespective of the number and combination of co-
occuring comorbidities.
For comparison with CTREE, classification and regres-
sion trees were computed for all cost sectors. As
expected, CARTs lead to bigger grown trees. In particu-
lar, in the case of nursing care 19 nodes emerged,
resulting in 10 subsets including as splitting criteria PD,
logarithmic income, Diabetes mellitus, cerebral ische-
mia/chronic stroke, age, liver diseases and cancers. At
the same time, similar to the CTREE algorithm, the first
split was caused by PD. With respect to total cost, 11
nodes resulted using CART, including PD, cardiac insuf-
ficiency, cerebral ischemia/chronic stroke, osteoporosis
and renal insufficiency. Thus, CART included three add-
itional diseases compared to CTREE. In case of medica-
tion costs, 7 nodes were identified by CART consisting
of PD, asthma/chronic obstructive pulmonary disease
and logarithmic income. Furthermore, opposite to
CTREE, CART resulted in 5 nodes for outpatient care.
These include logarithmic income and osteoporosis as
splitting variables. Finally, 9 nodes emerged for costs of in-
patient care, including cerebral ischemia/chronic stroke,
neuropathies, urinary incontinence and cardiac arrhythmia
as split variables. Compared to CTREE, only cerebral is-
chemia/chronic stroke was used as nodes in both tree
algorithms.
In order to control for overfitting and finding the opti-
mal CART based tree size, minimal cost-complexity
pruning was applied. This method was not able to find
any suitable tree in any cost sector.
Mean absolute errors of CTREEs and the “not pruned”
CARTs are reported in Table 4. For costs of outpatient= Parkinson’s disease; rd age = rounded age; logincome = natural
€ in 6-month period.
Table 4 Comparison of absolute mean error of CTREE and
CART algorithms for different cost sectors
Cost sector Mean absolute error
CTREE CART
Total costs 3,690.87 3,611.64
Outpatient care 284.09 293.39
Inpatient care 1,761.90 1,709.78
Medication 2,012.37 1,919.07
Nursing care 388.12 398.37
CART = classification and regression tree; CTREE = conditional inference tree.
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mean absolute error value compared to CART. However,
with respect to total costs, costs of medication and costs
of inpatient care CART lead to smaller error terms. All
splitting variables of CTREE were used as splitting vari-
able of the trees grown by CART.
Discussion
The partitioning conditional tree algorithm allows to de-
tect the underlying structure of how certain diseases
within arbitrary multimorbidity patterns influence the
costs of health care. Using this statistical approach, we
found various variables which are associated with total
costs, inpatient costs, medication costs and nursing care
costs in multimorbid elderly. These results were verified
using ensemble methods.
With respect to total costs and independent from the
other co-existing comorbidities, PD and cardiac insuffi-
ciency were identified as the most influencial variables,
with PD being the more important one. Compared to
patients not suffering from any of the two conditions,
PD increases predicted mean total costs 3.5-fold to ap-
proximately € 11,000 per 6 months, and cardiac insuffi-
ciency 2-fold to approximately € 6,100.
The high total costs of PD are largely due to costs of
nursing care, for which the respective partitioning tree
model predicted more than € 7,000 on average in this
patient group. When excluding nursing care from total
costs, PD disappeared in the tree for total costs, while
the split from cardiac insufficiency remained significant
(p = 0.004), predicting mean total costs of € 3,790 (n =
132) if cardiac insufficiency is present and € 2,177 (n =
918) otherwise (tree not shown). The same reduced tree
structure resulted when only excluding costs of informal
nursing care from total cost, predicting mean total costs
of € 4,052 if cardiac insufficiency is present and € 2,260
otherwise (p = 0.001; tree not shown), and reflecting that
high nursing costs of PD are largely due to informal
care.
If PD is not present, mean nursing care costs are
influenced by income and age, with low income being
associated with higher costs and, in those with higherincome, age being associated with higher costs. Taking
comparatively more affluent patients aged ≤76 years not
suffering from PD as the reference group, patients with
similar income in the age groups 77–83 and >83 cause
more than 3-fold and almost 11-fold mean nursing
costs, respectively, if PD is not present. If PD is present,
mean nursing costs are elevated almost 21-fold com-
pared to the same reference group, irrespective of age
and income. In patients with comparatively low income
without PD, mean nursing costs are increased almost 5-
fold compared to the reference group irrespective of age.
PD was also found to increase medication costs. Yet
concerning medication costs, the coexistence of COPD
and insomnia was identified as being associated with the
highest mean medication costs. Besides these conditions,
Diabetes mellitus significantly increases medication costs
if COPD and PD are not present. Compared to patients
in whom neither Diabetes nor PD or COPD are present,
Diabetes (without PD) increases mean medication costs
by 40%, PD by 222%, and COPD by 66% or even 271% if
insomnia is also present.
While the partitioning tree algorithm identified no
variable significantly associated with outpatient costs,
cerebral ischemia and/or chronic stroke (CI/CS) was
found to increase inpatient costs 3.5-fold, with no other
variables being significant in the model.
Except for costs of nursing care, socio-demographic
variables did not significantly influence costs of care.
Strengths and limitations
In general, one main advantage concerning partitioning
tree algorithms compared to traditional analytical
methods is to be seen in the simplified representation of
high dimensional data and its direct interpretability. Due
to the chosen 0/1 recursive partitioning framework, the
lack of smoothness - a common disadvantage of tree
based modelling - could be neglected.
Compared to classical parametric regression tech-
niques, tree-based decision models avoid any distribu-
tional assumption. Therefore, the estimation of the
coefficients is not affected by misspecification. At the
same time, trees aim to discriminate disjunctive homo-
geneous subsets by minimizing within-variance and
maximizing between-variance.
As a main disadvantage, CART or related decision tree
algorithms like C4.5 face high variance caused by the in-
herent binary partitioning method, leading to a propaga-
tion of the error effect of the first split. Besides this, due
to their focus on the maximization of the information
criteria, the problem of overfitting and a selection bias
of covariates with a maximum number of possible splits
as a result of the numerical optimization arises.
Instead of using traditional classification and regres-
sion trees (CART) or related tree algorithms like ID3 or
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context of statistical inferential theory (see [29,33]). We
used a conditional inference tree (CTREE) based on
multiple permutation tests which combines tree based
regression and statistical theory of conditional inference.
Opposite to CART or C4.5, CTREE controls for selec-
tion bias using splits based on statistical inference and
significance values. Permutation tests are implemented
to guarantee a solid stopping criteria. Thus, our model
overcomes typical problems of classical tree algorithms.
To verify our results and detected splitting variables,
variable importance scores were calculated based on
conditional random forests for each cost sector.
When comparing CTREE results to CART, in all cost
sectors CART lead to more splits on the one hand, while
pruning lead to no suitable trees. On the other hand,
CART verified the findings of CTREE by showing identi-
cal nodes and/or grown tree structures. Furthermore,
CTREE lead to theoretically reasonable splitting vari-
ables. Based on these findings as well as on calculated
error terms and results achieved from the conditional
random forests, our study emphasizes the superiority of
the CTREE algorithm.
Our statistical analysis was based on a pre-imputed
master data set provided by the data management of the
MultiCare study group which had used the hot deck
method and conditional means for imputation of miss-
ing values. Although we are aware of benefits resulting
from multiple imputation algorithms, we agreed on
using the master data set for the sake of consistency and
because the proportion of missing values in the variables
used for our analysis was very small. Nevertheless, tree-
based algorithms can handle complete data as well as
missing data usually assuming Missing Completely At
Random (MCAR).
Patients with response-limitations due to medical rea-
sons (blindness, deafness, dementia, etc.) as well as nurs-
ing home residents were excluded from the study
sample. Therefore the impact of respective chronic con-
ditions on health care costs could not be analyzed. Yet
conditions associated with response-difficulties may
strongly influence health care costs. For example, de-
mentia is a very important and prevalent condition in
the elderly associated with high health care costs. De-
mentia is often present in late stages of different dis-
eases, such as PD, CI, chronic stroke and others. Future
studies analyzing the impact of multimorbidity on health
care costs should therefore consider surrogate re-
sponders for data collection in such response-limiting
conditions.
Conclusions
In elderly patients suffering from multiple chronic con-
ditions, PD and cardiac insufficiency appear to be thechronic diseases most influential on total health care
costs irrespective of the number and combination of
other co-existing chronic conditions. Irrespective of any
combination and number of co-occurring diseases, costs
are significantly influenced by only a limited number of
factors.
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